Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy

Conservative Treatment ◽

Randomized Trial ◽

Phase Ii ◽

Resection of locally advanced pancreatic cancer after neoadjuvant chemotherapy with modified FOLFIRINOX: A prospective phase II study

Pancreatology ◽

10.1016/j.pan.2013.04.310 ◽

2013 ◽

Vol 13 (3) ◽

pp. S88-S89

Author(s):

Nelide De Lio ◽

Enrico Vasile ◽

Mario Antonio Belluomini ◽

Francesca Costa ◽

Carla Cappelli ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Pancreatic Cancer ◽

Locally Advanced Pancreatic Cancer ◽

Prospective Phase II Randomized Trial Comparing Proton Therapy vs. IMRT for Newly Diagnosed GBM: Secondary Analysis Comparison of Progression Free Survival between Clinical Radiological Assessment vs. Response Assessment in Neuro-Oncology (RANO)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.132 ◽

2019 ◽

Vol 105 (1) ◽

pp. S139

Author(s):

K.A. Al Feghali ◽

J.W. Randall ◽

J.S. Wefel ◽

N. Guha-Thakurta ◽

D.R. Grosshans ◽

...

Keyword(s):

Randomized Trial ◽

Phase Ii ◽

Proton Therapy ◽

Secondary Analysis ◽

Progression Free Survival ◽

Response Assessment ◽

Radiological Assessment ◽

Newly Diagnosed ◽

Free Survival ◽

Interim Safety and Toxicity Analysis of a Prospective Phase II Randomized Trial of Checkpoint Blockade Immunotherapy Combined with Stereotactic Body Radiation Therapy in Advanced Metastatic Disease

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.1046 ◽

2018 ◽

Vol 102 (3) ◽

pp. e343-e344

Author(s):

A. Sharabi ◽

S. Kim ◽

J. Proudfoot ◽

S. Kato ◽

H. Patel ◽

...

Keyword(s):

Radiation Therapy ◽

Randomized Trial ◽

Phase Ii ◽

Metastatic Disease ◽

Stereotactic Body Radiation Therapy ◽

Checkpoint Blockade ◽

Stereotactic Body Radiation ◽

Prospective Phase ◽

Toxicity Analysis ◽

Safety And Toxicity

ACTR-72. A PROSPECTIVE PHASE II RANDOMIZED TRIAL TO COMPARE INTENSITY MODULATED PROTON RADIOTHERAPY (IMPT) VS. INTENSITY MODULATED RADIOTHERAPY (IMRT) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

Neuro-Oncology ◽

10.1093/neuonc/nox168.059 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi16-vi16 ◽

Cited By ~ 1

Author(s):

Caroline Chung ◽

Paul D Brown ◽

Sarah McAvoy ◽

David R Grosshans ◽

Seyedeh Dibaj ◽

...

Keyword(s):

Randomized Trial ◽

Phase Ii ◽

Intensity Modulated Radiotherapy ◽

Newly Diagnosed ◽

Proton Radiotherapy ◽

Intensity Modulated ◽

Newly Diagnosed Glioblastoma ◽

Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trial

Acta Oncologica ◽

10.3109/0284186x.2013.781673 ◽

2013 ◽

Vol 53 (1) ◽

pp. 65-74 ◽

Cited By ~ 75

Author(s):

Whitney E. Hornsby ◽

Pamela S. Douglas ◽

Miranda J. West ◽

Aarti A. Kenjale ◽

Amy R. Lane ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Cancer Patients ◽

Phase Ii ◽

Aerobic Training ◽

Operable Breast Cancer ◽

Breast Cancer Patients ◽

Safety And Efficacy

LBA-17 MULTICENTER PROSPECTIVE PHASE II CLINICAL TRIAL OF GEMCITABINE AND CISPLATIN AS NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA

The Journal of Urology ◽

10.1097/01.ju.0000557509.30958.ae ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Jonathan A. Coleman* ◽

Nathan C. Wong ◽

Daniel D. Sjoberg ◽

Nicholas Silva ◽

Bernard H. Bochner ◽

...

Keyword(s):

Clinical Trial ◽

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Upper Tract Urothelial Carcinoma ◽

High Grade ◽

Upper Tract ◽

Prospective Phase ◽

Gemcitabine And Cisplatin

Abstract OT3-1-03: DIRECT: A phase II/III randomized trial with dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative breast cancer

10.1158/0008-5472.sabcs13-ot3-1-03 ◽

2013 ◽

Cited By ~ 1

Author(s):

S de Groot ◽

MPG Vreeswijk ◽

VTHBM Smit ◽

JB Heijns ◽

ALT Imholz ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Dietary Restriction

Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and S-1 (GS) for borderline resectable (BR)/unresectable (UR) pancreatic cancer (CAP-003 study).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e16225 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e16225-e16225

Author(s):

Hideyuki Yoshitomi ◽

Shigetsugu Takano ◽

Shingo Kagawa ◽

Katsunori Furukawa ◽

Tsukasa Takayashiki ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Borderline Resectable ◽

Activity Monitoring in Patients Receiving Concurrent Chemoradiation: Results from a Prospective Phase II Randomized Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.835 ◽

2020 ◽

Vol 108 (3) ◽

pp. S119

Author(s):

A.S. Grewal ◽

D. Farraday ◽

E. Ben-Josef ◽

J.M. Metz ◽

J.P. Plastaras ◽

...

Keyword(s):

Randomized Trial ◽

Phase Ii ◽

Activity Monitoring ◽

Concurrent Chemoradiation ◽

Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER+ HER2− Breast Cancer: A Prospective Phase II Study

Clinical Breast Cancer ◽

10.1016/j.clbc.2020.09.007 ◽

2020 ◽

Vol 20 (6) ◽

pp. 462-468

Author(s):

Naoki Hayashi ◽

Hiroshi Yagata ◽

Koichiro Tsugawa ◽

Yuka Kajiura ◽

Atsushi Yoshida ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Breast Cancer ◽